Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast CancerRoisín M. Connolly, Vered Stearns, Lilja B. Sólnes et al.|Journal of Clinical Oncology|2021Cited by 46